Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik – 25 September 2019
Morten A. Karsdal, Sönke Detlefsen, Samuel J. Daniels, Mette J. Nielsen, Aleksander Krag, Detlef Schuppan – 25 September 2019
Mazen Noureddin, Shira Zelber‐Sagi, Lynne R. Wilkens, Jacqueline Porcel, Carol J. Boushey, Loïc Le Marchand, Hugo R. Rosen, Veronica Wendy Setiawan – 25 September 2019
Our understanding of liver disease pathogenesis and manifestations in cystic fibrosis is evolving, as ongoing research and clinical experience expands. This webinar will provide updates on current understanding of CLFD pathogenesis, on strategies for diagnosis and monitoring, and on management of CFLD complications. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .A. Jay Freeman Dr.
Elizabeth C. Goode, Gideon M. Hirschfield, Simon M. Rushbrook – 24 September 2019
Yasuhiro Nakano, Akihide Kamiya, Hideaki Sumiyoshi, Kota Tsuruya, Tatehiro Kagawa, Yutaka Inagaki – 24 September 2019
Lane H. Wilson, Jun‐Ho Cho, Ana Estrella, Joan A. Smyth, Rong Wu, Tayoot Chengsupanimit, Laurie M. Brown, David A. Weinstein, Young Mok Lee – 24 September 2019 – Mutations in the liver glycogen phosphorylase (Pygl) gene are associated with the diagnosis of glycogen storage disease type VI (GSD‐VI). To understand the pathogenesis of GSD‐VI, we generated a mouse model with Pygl deficiency (Pygl−/−). Pygl−/− mice exhibit hepatomegaly, excessive hepatic glycogen accumulation, and low hepatic free glucose along with lower fasting blood glucose levels and elevated blood ketone bodies.
Young‐Chae Kim, Hyunkyung Jung, Sunmi Seok, Yang Zhang, Jian Ma, Tiangang Li, Byron Kemper, Jongsook Kim Kemper – 24 September 2019
Junfeng Wang, Ronald B. Geskus, Mariska M.G. Leeflang, Cyriel Y. Ponsioen – 23 September 2019
Tess McClure, Marcus Robertson – 23 September 2019